Savefor later Page saved! You can go back to this later in your Diabetes and Me Close

Diabetes Research Steering Group 2: Type 1 treatments and prevention

Current priorities:

  • Beta cell regeneration
  • Closed loop, pump, and CGM technology
  • C-peptide and glucose variability - residual insulin production
  • Glucagon and its role in type 1 diabetes
  • Hormones in type 1 diabetes
  • Insulin resistance in type 1 diabetes
  • Mental health and type 1 diabetes
  • Prevention and population screening
  • Patient Reported Outcome Measures (PROMs) and quality of life

Chair: Professor James Shaw, Newcastle University

Professor of Regenerative Medicine for Diabetes, Director of the Transplant Regenerative Medicine Laboratories and clinician scientist Lead for the Regenerative Medicine, Stem Cells and Transplantation Research Theme at Newcastle University. James also Chairs numerous important groups and is a consultant diabetologist in Newcastle and active researcher currently focusing on hypoglycaemia and islet transplantation.

Who's involved?

  • Bekki Millar
  • Hannah Sutton
  • Alex Clarke
  • Sarah Jarrett
  • Andrew Brasher
  • Dr Ildem Akerman
  • Dr Jill Carlton
  • Dr Gill Rees
  • Dr Ahmed Iqbal
  • Dr Robert Lindsay 
  • Dr Sufyan Hussain 
  • Dr Alison McNeilly
  • Dr Matthew Johnson

If you would like to share your views with the group on where research into prevention, targets and therapies for type 1 diabetes should be focused, please get in touch:

Back to Top
Brand Icons/Telephonecheck - FontAwesomeicons/tickicons/uk